| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACTN4
|
actinin, alpha 4
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
APC
|
adenomatous polyposis coli
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCDC88B
|
coiled-coil domain containing 88B
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DNM2
|
dynamin 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR2
|
early growth response 2
|
|
EPX
|
eosinophil peroxidase
|
|
ESRRB
|
estrogen-related receptor beta
|
|
ETM2
|
essential tremor 2
|
|
EXOSC3
|
exosome component 3
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GH2
|
growth hormone 2
|
|
HFE
|
hemochromatosis
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HNF1A
|
HNF1 homeobox A
|
|
IFNG
|
interferon, gamma
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
IL18
|
interleukin 18
|
|
IL23R
|
interleukin 23 receptor
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
MARVELD2
|
MARVEL domain containing 2
|
|
MC4R
|
melanocortin 4 receptor
|
|
MFN2
|
mitofusin 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUTYH
|
mutY homolog
|
|
NBN
|
nibrin
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NF1
|
neurofibromin 1
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX4
|
paired box 4
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
POMC
|
proopiomelanocortin
|
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPS26
|
ribosomal protein S26
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
|
SHOX
|
short stature homeobox
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SYN3
|
synapsin III
|
|
TBP
|
TATA box binding protein
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
